Vanguard Capital Management
ATYR icon

Vanguard Capital Management’s aTyr Pharma ATYR Stock Holding History

Vanguard Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.14M Sell
94,053
-1,149
-1% -$22.3K ﹤0.01% 3528
2026
Q2 		$2.27M Sell
95,202
-101
-0.1% -$2.64K ﹤0.01% 3382
2026
Q1 		$2.97M Buy
+95,303
New +$3.22M ﹤0.01% 3239

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Vanguard Capital Management's ATYR Position: Q3 2026 in Review

Vanguard Capital Management reduced its aTyr Pharma (ATYR) stake by 1.2% in Q3 2026, selling an estimated $22.3K and leaving 94,053 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3528.

Vanguard Capital Management first reported a position in ATYR in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.97M in Q1 2026. 51 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Vanguard Capital Management held 94,053 shares of aTyr Pharma worth $1.14M as of Q3 2026.
  • Vanguard Capital Management sold 1,149 aTyr Pharma shares in Q3 2026, an estimated $22.3K.
  • aTyr Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3528 holding.
  • Vanguard Capital Management first reported a position in aTyr Pharma in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's aTyr Pharma position peaked at $2.97M in Q1 2026.
  • 51 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.